Skip to main content

Table 4 Number of injections tested for purity by the Formulation WG

From: Scientific and regulatory approaches to confirm quality and improve patient perceptions of generic drug products in Japan

API

Formulation

Strength

Products

Method

Cefazolin sodium

Injection/sterile powders for injection

1 g/vial

5

JP (formulation)

Cisplatin

Injection/solutions

10 mg/vial

6

JP (API), EP, Approval documentation

Elcatonin injection

Injection/solutions

10 elcatonin/1 mL/vial

13

JP (API)

Famotidine

Injection/sterile powders for injection

20 mg/vial

6

JP (formulation)

Injection/solutions

20 mg/vial

1

Approval documentation

Iopamidol

Injection/solutions

61.24 % 50 mL/vial

4

JP (API)

Minocycline hydrochloride for injection

Injection/sterile powders for injection

100 mg/vial

6

JP (formulation)

Nafamostat mesilate

Injection/sterile powders for injection

10 mg/vial

15

Approval documentation

Nicardipine hydrochloride

Injection/solutions

10 mg/vial

7

JP (formulation)

Ozagrel sodium

Injection/sterile powders for injection

20 mg/vial

11

JP (formulation)

Injection/solutions

20 mg/vial, 80 mg/vial

5

Approval documentation

Piperacillin sodium

Injection/sterile powders for injection

1 g/vial

7

JP (formulation)

Ritodrine hydrochloride

Injection/solutions

50 mg/vial

10

JP (API)

Sulbactam sodium/Ampicillin sodium

Injection/sterile powders for injection

1.5 g/vial

9

Approval documentation

Vancomycin hydrochloride

Injection/sterile powders for injection

0.5 g/vial

8

JP (formulation)

Total

13 formulations

 

113 products

Â